20 September 2017: Sysmex partner with Pantai Premier Pathology and Merck for new liquid biopsy testing to be used in Metastatic cases of colorectal cancer

Colorectal cancer is the second most commonly occurring cancer in Malaysia (Malaysian National Cancer Registry Report 2007-2011). A new liquid biopsy testing to monitor the progression of metastatic cases of colorectal cancer has been developed by Sysmex Inostics in collaboration with Merck and is exclusively available in Pantai Premier Pathology, Malaysia.

13 September 2017: Sysmex Selected for Inclusion in the Dow Jones Sustainability World Index for the Second Consecutive Year

The Dow Jones Sustainability Indexes are developed through collaboration between S&P Dow Jones Indices of the United States and Robeco SAM, a Swiss research specialist in the area of socially responsible investment. This year Sysmex has been selected for inclusion in the DJSI World for the second consecutive year.